RANTES and MIP-1beta mRNA expression in human peripheral blood mononuclear cells: transcript quantification using...

Area of Science:

• Immunology and Virology
• Molecular Biology

Background:

• Chemokines, particularly CC-chemokines, play vital roles in immune responses and disease pathology.
• CC-chemokines and their receptors are implicated in the mechanisms and pathogenesis of Human Immunodeficiency Virus type 1 (HIV-1) infection.
• Current protein-based assays for chemokine detection are limited in clinical settings.

Purpose of the Study:

• To develop sensitive and accurate assays for quantifying mRNA of CC-chemokines RANTES and MIP-1beta.
• To assess the utility of these assays in analyzing peripheral blood mononuclear cells (PBMCs) from both healthy and HIV-1 infected individuals.

Main Methods:

• Nucleic Acid Sequence-Based Amplification (NASBA) technology was employed to create mRNA quantification assays.
• Assays were validated for sensitivity, accuracy, and reproducibility across a wide dynamic range.
• Methods were applied to analyze mRNA levels in PBMCs from normal and HIV-1 positive subjects.

Main Results:

• NASBA-based assays demonstrated high sensitivity, accuracy, and reproducibility (inter-assay comparable to intra-assay).
• MIP-1beta mRNA levels were consistently higher than RANTES mRNA levels in both normal and HIV-1 infected PBMCs.
• RANTES mRNA levels were significantly elevated in PBMCs from HIV-1 positive individuals compared to normal individuals.

Conclusions:

• Developed NASBA assays provide a sensitive and reproducible method for quantifying RANTES and MIP-1beta mRNA.
• The assays are valuable tools for studying chemokine expression in HIV-1 infection and potentially for clinical diagnostics.
• Findings highlight altered RANTES expression in HIV-1 infection, suggesting its role in disease progression.